Article(id=1322906838680863719, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887806737825858, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1629734400000, acceptedDateStr=2021-08-24, onlineDate=1793335168761, onlineDateStr=2026-10-30, pubDate=1634227200000, pubDateStr=2021-10-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793335168761, onlineIssueDateStr=2026-10-30, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793335168761, creator=13701087609, updateTime=1793335168761, updator=13701087609, issue=Issue{id=1322887806737825858, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='19', pageStart='1729', pageEnd='1824', issueExtLink='null', onlineDate='null', pubDate='1634227200000', pubDateStr='2021-10-15', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793330631192, creator='13701087609', updateTime=1793337389212, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322916151994495727, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887806737825858, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322916151994495728, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887806737825858, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1738, endPage=1745, ext={EN=ArticleExt(id=1322906838861218792, articleId=1322906838680863719, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Quality study of recombinant anti-interleukin-23 monoclonal antibodies, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective: To develop quality control methods for recombinant anti-interleukin-23 monoclonal antibodies (anti-IL23 mAb).
Methods: Peptide map analysis by RP-HPLC was used for identification of an anti-IL-23 mAb. The purity was measured by reduced/non-reduced capillary electrophoresis-sodium dodecyl sulfonate (CE-SDS) and size exclusion-high performance liquid chromatography (SEC-HPLC). Charge heterogeneity was measured by imaging capillary isoelectric focusing electrophoresis (icIEF). LC isoAsp95 was measured by RP-HPLC. The biological activity was determined on U2OS IL23R/IL12RB1 dimerization cell. Other quality control items complied with corresponding requirements of “Chinese Pharmacopeia” 2015 edition and related guidelines.
Results: Peptide mapping showed the specific spectrum of the anti-IL23 mAb, which could be adopted for the identification test. The area percentage of heavy chain, NGHC and light chain was (97.84±0.12)% as detected by reduced CE-SDS; the area percentage of main peak detected by non-reduced CE-SDS was (97.23±0.11)%. The area percentage of monomer peak and total aggregate peak detected by SEC-HPLC were (99.26±0.005)% and (0.71±0.005)%, respectively. The area percentage of main peak, acid peak and alkaline peak detected by icIEF were (73.83±0.29)%, (24.03±0.34)% and (2.10±0.09)%, respectively. The percentage of LC isoAsp95 was (3.37±0.52)%. The relative biological activity was (102.25±8.47)%.
Conclusion: A series of quality control methods for anti-IL23 mAbs has been established, which can be adaptable in ensuring the safety, effectiveness and quality controllability for similar biologics. The study is of great significance as a representative quality control reference for anti-IL23 mAbs.
, authors=Zhi-hao FU, Gang WU, Meng LI, Yong-fei CUI, Lan WANG, authorsList=Zhi-hao FU, Gang WU, Meng LI, Yong-fei CUI, Lan WANG, authorCompany=null, correspAuthors=Lan WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322906839196763113, articleId=1322906838680863719, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=重组抗白细胞介素23单克隆抗体的质量研究, columnId=1236330552693944345, journalTitle=中国新药杂志, columnName=生物医药前沿, runingTitle=null, highlight=null, articleAbstract=
目的: 针对白细胞介素-23单克隆抗体(抗IL-23单抗)的关键质量属性建立质控方法。
方法: 采用基于反向高效液相色谱法(RP-HPLC)的肽图法进行鉴别;采用还原/非还原十二烷基磺酸钠毛细管电泳(CE-SDS)和分子排阻色谱(SEC-HPLC)进行纯度控制;采用成像毛细管等电聚焦电泳(icIEF)测定电荷异质性;采用RP-HPLC测定轻链95位天冬氨酸异构体(light chain isoAsp95,LC isoAsp95);采用基于U2OS IL23R/IL12RB1二聚化分析细胞的化学发光法测定生物学活性。其他各项指标均应符合《中华人民共和国药典》2015年版以及其他相关要求。
结果: 肽图检测具有特征图谱,起到很好的鉴别作用。还原CE-SDS的重链、非糖基化重链(nonglycosylated heavy chain,NGHC)和轻链峰面积之和百分比为(97.84±0.12)%,非还原CE-SDS主峰峰面积百分比为(97.23±0.11)%;SEC-HPLC单体的峰面积百分比为(99.26±0.005)%,总聚集体峰面积百分比为(0.71±0.005)%。icIEF分析的主峰的峰面积百分比为(73.83±0.29)%,酸性峰的峰面积百分比为(24.03±0.34)%,碱性峰的峰面积百分比为(2.10±0.09)%;供试品LC isoAsp95的百分比为(3.37±0.52)%;供试品相对于参比品的相对生物学活性为(102.25±8.47)%。
结论: 针对抗IL-23单抗的质量属性,研究建立质控方法并进行质量研究,确保产品的安全有效且质量可控,对抗IL-23单抗的质量控制具有借鉴意义。
, authors=付志浩, 武刚, 李萌, 崔永霏, 王兰, authorsList=付志浩, 武刚, 李萌, 崔永霏, 王兰, authorCompany=null, correspAuthors=王兰, authorNote=
, correspAuthorsNote=
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=N1i3NH1YWp5dkE6soksgNA==, magXml=cUDC09+lITP/pFv3sn8mlQ==, pdfUrl=null, pdf=OCXKidHQLSQL8/eWEGmQkQ==, pdfFileSize=1329783, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=MMVQL9DRX/1mqBnnrRo21Q==, mapNumber=null, fund=null)}, authors=[Author(id=1322906839591027694, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=fuzhihao@nifdc.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906841285526512, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906839591027694, language=EN, stringName=Zhi-hao FU, firstName=Zhi-hao, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906841361023985, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906839591027694, language=CN, stringName=付志浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629, bio={"content":"
付志浩,男,副研究员,主要从事单克隆抗体质量控制研究。E-mail:fuzhihao@nifdc.org.cn。
"}, bioImg=null, bioContent=
付志浩,男,副研究员,主要从事单克隆抗体质量控制研究。E-mail:fuzhihao@nifdc.org.cn。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])]), Author(id=1322906841436521459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wugangcailiao@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906841545573365, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841436521459, language=EN, stringName=Gang WU, firstName=Gang, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906841616876534, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841436521459, language=CN, stringName=武刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])]), Author(id=1322906841696568312, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906841784648698, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841696568312, language=EN, stringName=Meng LI, firstName=Meng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906841868534779, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841696568312, language=CN, stringName=李萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])]), Author(id=1322906841948226557, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906842027918335, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841948226557, language=EN, stringName=Yong-fei CUI, firstName=Yong-fei, middleName=null, lastName=CUI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906842099221504, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906841948226557, language=CN, stringName=崔永霏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])]), Author(id=1322906842166329345, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=iamouran@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906842237632515, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906842166329345, language=EN, stringName=Lan WANG, firstName=Lan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906842313129988, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, authorId=1322906842166329345, language=CN, stringName=王兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])])], keywords=[Keyword(id=1322906842405404677, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=EN, orderNo=1, keyword=anti-interleukin-23 monoclonal antibodies), Keyword(id=1322906842476707846, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=EN, orderNo=2, keyword=psoriasis), Keyword(id=1322906842552205319, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=EN, orderNo=3, keyword=peptide mapping identification), Keyword(id=1322906842636091400, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=EN, orderNo=4, keyword=purity determination), Keyword(id=1322906842711588873, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=EN, orderNo=5, keyword=biological activity), Keyword(id=1322906842787086346, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=CN, orderNo=1, keyword=抗白细胞介素23单克隆抗体), Keyword(id=1322906842854195211, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=CN, orderNo=2, keyword=银屑病), Keyword(id=1322906842925498380, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=CN, orderNo=3, keyword=肽图鉴别), Keyword(id=1322906842992607245, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=CN, orderNo=4, keyword=纯度测定), Keyword(id=1322906843068104718, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, language=CN, orderNo=5, keyword=生物学活性)], refs=[Reference(id=1322906843386871825, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=OPPMANN B, LESLEY R, BLOM B,
et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12[J].
Immunity, 2000, 13(5): 715-725., articleTitle=null, refAbstract=null), Reference(id=1322906843483340818, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=CAULI A, PIGA M, FLORIS A,
et al. Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)[J].
Immunotargets Ther, 2015, 4: 185-190., articleTitle=null, refAbstract=null), Reference(id=1322906843567226899, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=DUVALLET E, SEMERANO L, ASSIER E,
et al. Interleukin-23: a key cytokine in inflammatory diseases[J].
Ann Med, 2011, 43(7): 503-511., articleTitle=null, refAbstract=null), Reference(id=1322906843638530068, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=CAPON F, BARKER JN. The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead[J].
Br J Dermatol, 2012, 166(6): 1173-1175., articleTitle=null, refAbstract=null), Reference(id=1322906843726610453, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=TORRES T, ROMANELLI M, CHIRICOZZI A. A revolutionary therapeutic approach for psoriasis: bispecific biological agents[J].
Expert Opin Investig Drugs, 2016, 25(7): 751-754., articleTitle=null, refAbstract=null), Reference(id=1322906843810496534, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=HAWKES JE, YAN BY, CHAN TC,
et al. Discovery of the IL-23/IL-17 signaling pathway and the treatment of psoriasis[J].
J Immunol, 2018, 201(6): 1605-1613., articleTitle=null, refAbstract=null), Reference(id=1322906843873411095, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=JEON C, SEKHON S, YAN D,
et al. Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis[J].
Hum Vaccines Immunother, 2017, 13(10): 2247-2259., articleTitle=null, refAbstract=null), Reference(id=1322906843927937048, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=ABROUK M, GANDY J, NAKAMURA M,
et al. Secukinumab in the treatment of psoriasis and psoriatic arthritis: a review of the literature[J].
Skin Ther Lett, 2017, 22(4): 1-6., articleTitle=null, refAbstract=null), Reference(id=1322906845723099161, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MAGDALENO-TAPIAL J, CARMENA-RAMÓN R, VALENZUELA-OÑATE C,
et al. Efficacy and safety of ixekizumab in a real-life practice: a retrospective bicentric study[J].
Actas Dermosifiliogr (Engl Ed), 2019, 110(7): 585-589., articleTitle=null, refAbstract=null), Reference(id=1322906845815373850, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=PUIG L. Brodalumab: The first anti-IL-17 receptor agent for psoriasis[J].
Drugs Today, 2017, 53(5): 283., articleTitle=null, refAbstract=null), Reference(id=1322906845903454235, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=ELBERDÍN L, FERNÁNDEZ-TORRES R, PARADELA S,
et al. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital[J].
J Dermatol Treat, 2020, 31(7): 698-701., articleTitle=null, refAbstract=null), Reference(id=1322906845983146012, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=BANGERT C, KOPP T. Tildrakizumab for the treatment of psoriasis[J].
Immunotherapy, 2018, 10(13): 1105-1122., articleTitle=null, refAbstract=null), Reference(id=1322906846146723869, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=MCKEAGE K, DUGGAN S. Risankizumab: first global approval[J].
Drugs, 2019, 79(8): 893-900., articleTitle=null, refAbstract=null), Reference(id=1322906846230609950, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKAMURA M, LEE K, JEON C,
et al. Guselkumab for the treatment of psoriasis: a review of phase III trials[J].
Dermatol Ther (Heidelb), 2017, 7(3): 281-292., articleTitle=null, refAbstract=null), Reference(id=1322906846327078943, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=LANGLEY RG, TSAI TF, FLAVIN S,
et al. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial[J].
Br J Dermatol, 2018, 178(1): 114-123., articleTitle=null, refAbstract=null), Reference(id=1322906846402576416, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=王军志. 生物技术药物研究开发和质量控制[M]. 第3版. 北京: 科学出版社, 2018., articleTitle=null, refAbstract=null), Reference(id=1322906846612291617, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ESPINOSA-DE LA GARZA CE, PERDOMO-ABUÚNDEZ FC, PADILLA-CALDERÓN J,
et al. Analysis of recombinant monoclonal antibodies by capillary zone electrophoresis[J].
Electrophoresis, 2013, 34(8): 1133-1140., articleTitle=null, refAbstract=null), Reference(id=1322906846700372002, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO J, SUN W, GONG F,
et al. Charge profiling and stability testing of biosimilar by capillary isoelectric focusing[J].
Electrophoresis, 2014, 35(10): 1461-1468., articleTitle=null, refAbstract=null), Reference(id=1322906846780063779, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WU G, YU C, WANG W,
et al. Interlaboratory method validation of icIEF methodology for analysis of monoclonal antibodies[J].
Electrophoresis, 2018, 39(16): 2091-2098., articleTitle=null, refAbstract=null), Reference(id=1322906846863949860, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=DU Y, WALSH A, EHRICK R,
et al. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies[J].
MAbs, 2012, 4(5): 578-585., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322906843198128143, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, awardId=2018ZX09736008-006, language=CN, fundingSource=国家“重大新药创制”科技重大专项资助项目(2018ZX09736008-006), fundOrder=null, country=null), Fund(id=1322906843269431312, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, awardId=null, language=CN, fundingSource=自身免疫疾病治疗的单抗类生物类似药质量评价和国家标准品建立, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322906839456809962, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, xref=null, ext=[AuthorCompanyExt(id=1322906839465198571, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Division of Monoclonal Antibodies, National Institutes for Food and Drug Control, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing 102629, China), AuthorCompanyExt(id=1322906839486170092, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906838680863719, companyId=1322906839456809962, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国食品药品检定研究院单克隆抗体产品室,卫生部生物技术产品检定方法及其标准化重点实验室,北京 102629)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I19/1738, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I19/1738, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I19/1738, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I19/1738, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1634227200000, fullTextJson=null, articleText=null, reference=null)